DEPLOYThe reference layer for physical AI

Deployment

RayNeo V3 at US Healthcare

RayNeo V3 is a camera-and-audio AI glasses product with no display, in the Ray-Ban Meta class, made by RayNeo, a brand under Thunderbird Innovation Technology in Shenzhen, founded in October 2021 and backed by TCL Electronics. RayNeo is the number-one global augmented-reality glasses brand by third-quarter 2025 share at 24 percent per Counterpoint, raised a $143 million round in January 2026, and has a deep partnership with Alibaba, which integrated its Tongyi Qianwen large language model into RayNeo products and took an equity stake. The V3 sells for about $245 to $255, weighs 39 grams, carries a 12-megapixel camera co-developed with TCL and 32 gigabytes of storage, went on sale in China in January 2025, and led the country's online AI smart-glasses category in the first quarter of 2025 at roughly 50 percent share with shipments in the tens of thousands, placing it at commercial mass-market maturity. Its AI is primary and genuine: the product is built around the assistant and first-person camera with ask-about-what-you-see as the core interaction rather than veneer, though it is cloud-dependent on Alibaba's Tongyi Qianwen rather than on-device. The registry records the V3 rather than the RayNeo X3 Pro that the dispatch listed, because the X3 Pro is a display-first augmented-reality device where AI is layered on a microLED waveguide display, failing the AI-as-primary test in the same way as the excluded Xreal. Vendor claims of a Snapdragon AR1 chip, 98 percent accuracy, and a 1.3-second response time are not independently verified.

RayNeo V3 by RayNeo · Catalog entry · 1 source · not yet field-verified


Machine-readable surfaces

US clinical and wellness wearable deployment. RayNeo V3 operations.

Trust tier
Catalog entry · 1 source · not yet field-verified
Last updated
2026-06-08
Model
RayNeo V3
Company
RayNeo
Location
US Healthcare
Status
operational
ID
19adc87b-5f0b-4071-aeda-49afb52ec603

Sources (1)

  1. https://rover.report
Methodology: Verified · 1 source (no primary) · last reviewed 2026-06-08

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-06-08

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: wearable

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for RayNeo V3 at US Healthcare.

Common questions

What is the RayNeo V3 deployment at US Healthcare?
RayNeo V3, built by RayNeo, is recorded as a deployment at US Healthcare on the DEPLOY registry. RayNeo operates the deployment directly.
Who operates RayNeo V3 at US Healthcare?
RayNeo, the manufacturer of RayNeo V3, operates this deployment directly. This is a maker-deploys-its-own-product arrangement rather than a customer pilot.
Have there been incidents at the RayNeo V3 deployment at US Healthcare?
No active incidents affecting this deployment are recorded on the DEPLOY registry. Absence of recorded incidents is not a guarantee no incident occurred; DEPLOY records only sourced incidents and suppresses retracted ones.

Deploy Watch

Track this deployment.

We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.